Significantly higher efficacy for sotrovimab compared with molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients during the UK Omicron wave
https://twitter.com/EricTopol/status/1528785295323254784?s=20&t=PLg8ieQmfFHBhVPjJKfK8g